C
CRISPR Therapeutics AG
Q3 2026 earnings expected
Quarter
Jul – Sep
Expected
November 9, 2026(ET)
Revenue Growth Trajectory
+1041%YoY
Last 7 quarters
Analyst consensus · $15M · 10 analysts
As of 8/30, 12:01 KST
CRISPR Therapeutics AG
Jul – Sep
November 9, 2026(ET)
Last 7 quarters
Analyst consensus · $15M · 10 analysts
As of 8/30, 12:01 KST